Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunjing Wu

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|June 21, 2017
Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer TherapyYing-Ying Li, Lynn G Feun, Angkana Thongkum, et al.
Molecular Cancer Research : MCR|October 20, 2019
Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung CancerDan J M Nguyen, George Theodoropoulos, Ying-Ying Li, et al.
Anticancer Research|December 16, 2014
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesotheliomaMedhi Wangpaichitr, Chunjing Wu, Gregory Bigford, et al.
Oncotarget|January 16, 2016
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanomaYing-Ying Li, Chunjing Wu, Shu-Mei Chen, et al.
Molecular Oncology|November 3, 2017
Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivationYing-Ying Li, Chunjing Wu, Sumedh S Shah, et al.
Oncotarget|May 20, 2017
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancerMedhi Wangpaichitr, Chunjing Wu, Ying Ying Li, et al.
Oncotarget|June 3, 2016
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapyZhongyi Yan, Yahong Wu, Jiangfeng Du, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Cancer & Metabolism|May 24, 2023
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancerChunjing Wu, Sydney A Spector, George Theodoropoulos, et al.
Cells|July 12, 2024
Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with ImmunotherapyEric P Knott, Emily Y Kim, Edison Q Kim, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Molecular Sciences|June 21, 2017
Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer TherapyYing-Ying Li, Lynn G Feun, Angkana Thongkum, et al.
Molecular Cancer Research : MCR|October 20, 2019
Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung CancerDan J M Nguyen, George Theodoropoulos, Ying-Ying Li, et al.
Anticancer Research|December 16, 2014
Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesotheliomaMedhi Wangpaichitr, Chunjing Wu, Gregory Bigford, et al.
Oncotarget|January 16, 2016
BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanomaYing-Ying Li, Chunjing Wu, Shu-Mei Chen, et al.
Molecular Oncology|November 3, 2017
Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivationYing-Ying Li, Chunjing Wu, Sumedh S Shah, et al.
Oncotarget|May 20, 2017
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancerMedhi Wangpaichitr, Chunjing Wu, Ying Ying Li, et al.
Oncotarget|June 3, 2016
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapyZhongyi Yan, Yahong Wu, Jiangfeng Du, et al.
Cancer|June 29, 2019
Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinomaLynn G Feun, Ying-Ying Li, Chunjing Wu, et al.
Cancer & Metabolism|May 24, 2023
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancerChunjing Wu, Sydney A Spector, George Theodoropoulos, et al.
Cells|July 12, 2024
Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with ImmunotherapyEric P Knott, Emily Y Kim, Edison Q Kim, et al.
Pageof 3